15 results on '"Rutschow D"'
Search Results
2. Synthesis of (Z)-1,2-bis(trimethylstannyl)-1-alkenes by platinum-catalysed addition of hexamethyldistannane to 1-alkynes
- Author
-
Mitchell, T.N., primary, Amamria, A., additional, Killing, H., additional, and Rutschow, D., additional
- Published
- 1983
- Full Text
- View/download PDF
3. Some chemistry of organotin synthons containing two organotin moieties
- Author
-
Mitchell, T.N., primary, Kwetkat, K., additional, Rutschow, D., additional, and Schneider, U., additional
- Published
- 1989
- Full Text
- View/download PDF
4. ChemInform Abstract: Some Chemistry of Organotin Synthons Containing Two Organotin Moieties.
- Author
-
MITCHELL, T. N., primary, KWETKAT, K., additional, RUTSCHOW, D., additional, and SCHNEIDER, U., additional
- Published
- 1989
- Full Text
- View/download PDF
5. ChemInform Abstract: SYNTHESIS OF (Z)-1,2-BIS(TRIMETHYLSTANNYL)-1-ALKENES BY PLATINUM-CATALYZED ADDITION OF HEXAMETHYLDISTANNANE TO 1-ALKYNES
- Author
-
MITCHELL, T. N., primary, AMAMRIA, A., additional, KILLING, H., additional, and RUTSCHOW, D., additional
- Published
- 1983
- Full Text
- View/download PDF
6. Palladium catalysis in organotin chemistry: addition of hexaalkylditins to alkynes
- Author
-
Mitchell, T.N., primary, Amamria, A., additional, Killing, H., additional, and Rutschow, D., additional
- Published
- 1986
- Full Text
- View/download PDF
7. ChemInform Abstract: Palladium Catalysis of Organotin Chemistry: Addition of Hexaalkylditins to Alkynes.
- Author
-
MITCHELL, T. N., primary, AMAMRIA, A., additional, KILLING, H., additional, and RUTSCHOW, D., additional
- Published
- 1987
- Full Text
- View/download PDF
8. S151A δ-sarcoglycan mutation causes a mild phenotype of cardiomyopathy in mice.
- Author
-
Rutschow D, Bauer R, Göhringer C, Bekeredjian R, Schinkel S, Straub V, Koenen M, Weichenhan D, Katus HA, and Müller OJ
- Subjects
- Animals, Cardiomyopathies etiology, Cardiomyopathies pathology, Dependovirus, Gene Knock-In Techniques, Heterozygote, Humans, Mice, Myocardium pathology, Phenotype, Cardiomyopathies genetics, Mutation, Missense, Sarcoglycans genetics
- Abstract
So far, the role of mutations in the δ-sarcogylcan (Sgcd) gene in causing autosomal dominant dilated cardiomyopathy (DCM) remains inconclusive. A p.S151A missense mutation in exon 6 of the Sgcd gene was reported to cause severe isolated autosomal dominant DCM without affecting skeletal muscle. This is controversial to our previous findings in a large consanguineous family where this p.S151A mutation showed no relevance for cardiac disease. In this study, the potential of the p.S151A mutation to cause DCM was investigated by using two different approaches: (1) engineering and characterization of heterozygous knock-in (S151A-) mice carrying the p.S151A mutation and (2) evaluation of the potential of adeno-associated virus (AAV) 9-based cardiac-specific transfer of p.S151A-mutated Sgcd cDNA to rescue the cardiac phenotype in Sgcd-deficient (Sgcd-null) mice as it has been demonstrated for intact, wild-type Sgcd cDNA. Heterozygous S151A knock-in mice developed a rather mild phenotype of cardiomyopathy. Increased heart to body weight suggests cardiac enlargement in 1-year-old S151A knock-in mice. However, at this age cardiac function, assessed by echocardiography, is maintained and histopathology completely absent. Myocardial expression of p.S151A cDNA, similar to intact Sgcd cDNA, restores cardiac function, although not being able to prevent myocardial histopathology in Sgcd-null mice completely. Our results suggest that the p.S151A mutation causes a mild, subclinical phenotype of cardiomyopathy, which is prone to be overseen in patients carrying such sequence variants. Furthermore, this study shows the suitability of an AAV-mediated cardiac gene transfer approach to analyze whether a sequence variant is a disease-causing mutation.
- Published
- 2014
- Full Text
- View/download PDF
9. Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex.
- Author
-
Krauss S, Griesche N, Jastrzebska E, Chen C, Rutschow D, Achmüller C, Dorn S, Boesch SM, Lalowski M, Wanker E, Schneider R, and Schweiger S
- Subjects
- Animals, Blotting, Western, HeLa Cells, Humans, Huntingtin Protein, Luciferases metabolism, Mice, Nerve Tissue Proteins metabolism, Nucleotide Motifs, Protein Binding, RNA, Messenger genetics, RNA, Messenger metabolism, TOR Serine-Threonine Kinases metabolism, Ubiquitin-Protein Ligases, Microtubule Proteins metabolism, Nerve Tissue Proteins genetics, Nuclear Proteins metabolism, Protein Biosynthesis genetics, Protein Phosphatase 2 metabolism, Transcription Factors metabolism, Trinucleotide Repeat Expansion genetics
- Abstract
Expansion of CAG repeats is a common feature of various neurodegenerative disorders, including Huntington's disease. Here we show that expanded CAG repeats bind to a translation regulatory protein complex containing MID1, protein phosphatase 2A and 40S ribosomal S6 kinase. Binding of the MID1-protein phosphatase 2A protein complex increases with CAG repeat size and stimulates translation of the CAG repeat expansion containing messenger RNA in a MID1-, protein phosphatase 2A- and mammalian target of rapamycin-dependent manner. Our data indicate that pathological CAG repeat expansions upregulate protein translation leading to an overproduction of aberrant protein and suggest that the MID1-complex may serve as a therapeutic target for the treatment of CAG repeat expansion disorders.
- Published
- 2013
- Full Text
- View/download PDF
10. Long-term preservation of cardiac structure and function after adeno-associated virus serotype 9-mediated microdystrophin gene transfer in mdx mice.
- Author
-
Schinkel S, Bauer R, Bekeredjian R, Stucka R, Rutschow D, Lochmüller H, Kleinschmidt JA, Katus HA, and Müller OJ
- Subjects
- Animals, Blotting, Western, Disease Models, Animal, Dystrophin metabolism, Humans, Mice, Mice, Inbred mdx, Myocardium metabolism, Polymerase Chain Reaction, Promoter Regions, Genetic, Dependovirus genetics, Dystrophin genetics, Genetic Therapy, Myocardium cytology
- Abstract
Dystrophin plays an important role in muscle contraction, linking the intracellular cytoskeleton to the extracellular matrix. Mutations of the dystrophin gene leading to a complete loss of the protein cause Duchenne muscular dystrophy (DMD), frequently associated with severe cardiomyopathy. Early clinical trials in DMD using gene transfer to skeletal muscle are underway, but gene transfer to dystrophic cardiac muscle has not yet been tested in humans. The aim of this study was to develop an optimized protocol for cardiac gene therapy in the mouse model of dystrophin deficiency (mdx), using a cardiac promoter for expression of a microdystrophin (μDys) transgene packaged into an adeno-associated virus serotype 9 vector (AAV9). In this study adult mdx mice were intravenously injected with 1×10(12) genomic particles of AAV9 vectors carrying a cDNA encoding μDys under the control of either a ubiquitously active cytomegalovirus (CMV) promoter or a cardiac-specific CMV-enhanced myosin light chain (MLC0.26) promoter. After 10 months, both AAV9 vectors led to sustained μDys expression in cardiac muscle, but the MLC promoter conferred about 4-fold higher protein levels. AAV9-CMV-MLC0.26-μDys resulted in significant protection of cardiac morphology and function as assessed by histopathology, echocardiography, and left ventricular catheterization. In conclusion, we established an AAV9-mediated gene transfer approach for efficient and specific long-term μDys expression in the hearts of mdx mice, resulting in a sustained therapeutic effect. Thus, this approach might be a basis for further translation into a treatment strategy for DMD-associated cardiomyopathy.
- Published
- 2012
- Full Text
- View/download PDF
11. Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1).
- Author
-
Aranda-Orgillés B, Rutschow D, Zeller R, Karagiannidis AI, Köhler A, Chen C, Wilson T, Krause S, Roepcke S, Lilley D, Schneider R, and Schweiger S
- Subjects
- 3-Phosphoinositide-Dependent Protein Kinases, Esophagus abnormalities, Esophagus metabolism, HeLa Cells, Humans, Hypertelorism genetics, Hypertelorism metabolism, Hypospadias genetics, Hypospadias metabolism, Microtubule Proteins genetics, Nuclear Proteins genetics, Protein Serine-Threonine Kinases genetics, RNA, Messenger genetics, RNA-Binding Proteins genetics, Transcription Factors genetics, Ubiquitin-Protein Ligases genetics, Microtubule Proteins metabolism, Nuclear Proteins metabolism, Protein Biosynthesis, Protein Serine-Threonine Kinases biosynthesis, RNA, Messenger metabolism, RNA-Binding Proteins metabolism, Transcription Factors metabolism, Ubiquitin-Protein Ligases metabolism
- Abstract
We have shown previously that the ubiquitin ligase MID1, mutations of which cause the midline malformation Opitz BBB/G syndrome (OS), serves as scaffold for a microtubule-associated protein complex that regulates protein phosphatase 2A (PP2A) activity in a ubiquitin-dependent manner. Here, we show that the MID1 protein complex associates with mRNAs via a purine-rich sequence motif called MIDAS (MID1 association sequence) and thereby increases stability and translational efficiency of these mRNAs. Strikingly, inclusion of multiple copies of the MIDAS motif into mammalian mRNAs increases production of the encoded proteins up to 20-fold. Mutated MID1, as found in OS patients, loses its influence on MIDAS-containing mRNAs, suggesting that the malformations in OS patients could be caused by failures in the regulation of cytoskeleton-bound protein translation. This is supported by the observation that the majority of mRNAs that carry MIDAS motifs is involved in developmental processes and/or energy homeostasis. Further analysis of one of the proteins encoded by a MIDAS-containing mRNA, namely PDPK-1 (3-phosphoinositide dependent protein kinase-1), which is an important regulator of mammalian target of rapamycin/PP2A signaling, showed that PDPK-1 protein synthesis is significantly reduced in cells from an OS patient compared with an age-matched control and can be rescued by functional MID1. Together, our data uncover a novel messenger ribonucleoprotein complex that regulates microtubule-associated protein translation. They suggest a novel mechanism underlying OS and point at an enormous potential of the MIDAS motif to increase the efficiency of biotechnological protein production in mammalian cells.
- Published
- 2011
- Full Text
- View/download PDF
12. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.
- Author
-
Kickstein E, Krauss S, Thornhill P, Rutschow D, Zeller R, Sharkey J, Williamson R, Fuchs M, Köhler A, Glossmann H, Schneider R, Sutherland C, and Schweiger S
- Subjects
- Adenylate Kinase metabolism, Alzheimer Disease metabolism, Alzheimer Disease pathology, Alzheimer Disease physiopathology, Animals, Cells, Cultured, Enzyme Inhibitors pharmacology, Epitopes, HeLa Cells, Humans, Hypoglycemic Agents pharmacology, Mechanistic Target of Rapamycin Complex 1, Mice, Mice, Transgenic, Multiprotein Complexes, Neurofibrillary Tangles pathology, Neurons cytology, Neurons metabolism, Okadaic Acid pharmacology, Phosphorylation, Protein Phosphatase 2 genetics, Proteins metabolism, Signal Transduction drug effects, TOR Serine-Threonine Kinases genetics, tau Proteins genetics, Metformin pharmacology, Neurofibrillary Tangles metabolism, Protein Phosphatase 2 metabolism, TOR Serine-Threonine Kinases metabolism, tau Proteins metabolism
- Abstract
Hyperphosphorylated tau plays an important role in the formation of neurofibrillary tangles in brains of patients with Alzheimer's disease (AD) and related tauopathies and is a crucial factor in the pathogenesis of these disorders. Though diverse kinases have been implicated in tau phosphorylation, protein phosphatase 2A (PP2A) seems to be the major tau phosphatase. Using murine primary neurons from wild-type and human tau transgenic mice, we show that the antidiabetic drug metformin induces PP2A activity and reduces tau phosphorylation at PP2A-dependent epitopes in vitro and in vivo. This tau dephosphorylating potency can be blocked entirely by the PP2A inhibitors okadaic acid and fostriecin, confirming that PP2A is an important mediator of the observed effects. Surprisingly, metformin effects on PP2A activity and tau phosphorylation seem to be independent of AMPK activation, because in our experiments (i) metformin induces PP2A activity before and at lower levels than AMPK activity and (ii) the AMPK activator AICAR does not influence the phosphorylation of tau at the sites analyzed. Affinity chromatography and immunoprecipitation experiments together with PP2A activity assays indicate that metformin interferes with the association of the catalytic subunit of PP2A (PP2Ac) to the so-called MID1-α4 protein complex, which regulates the degradation of PP2Ac and thereby influences PP2A activity. In summary, our data suggest a potential beneficial role of biguanides such as metformin in the prophylaxis and/or therapy of AD.
- Published
- 2010
- Full Text
- View/download PDF
13. Prevention of cardiomyopathy in delta-sarcoglycan knockout mice after systemic transfer of targeted adeno-associated viral vectors.
- Author
-
Goehringer C, Rutschow D, Bauer R, Schinkel S, Weichenhan D, Bekeredjian R, Straub V, Kleinschmidt JA, Katus HA, and Müller OJ
- Subjects
- Animals, Exercise Test, Gene Transfer Techniques, Genetic Vectors, Heart Failure prevention & control, Injections, Intravenous, Mice, Mice, Inbred C57BL, Mice, Knockout, Muscle, Skeletal metabolism, Myocardium pathology, Sarcoglycans metabolism, Ventricular Function, Left, Cardiomyopathies prevention & control, Dependovirus, Genetic Therapy, Myocardium metabolism, Sarcoglycans genetics
- Abstract
Aims: Delta-sarcoglycan is a member of the dystrophin-associated glycoprotein complex linking the cytoskeleton to the extracellular matrix. Similar to patients with defects in the gene encoding delta-sarcoglycan (Sgcd), knockout mice develop cardiomyopathy and muscular dystrophy. The aim of our study was to develop an approach for preventing cardiomyopathy in Sgcd-deficient mice by cardiac expression of the intact cDNA upon systemic delivery of adeno-associated viral (AAV) vectors., Methods and Results: We packaged the Sgcd cDNA under transcriptional control of a myosin light chain-promoter fused with a cytomegalovirus enhancer into AAV-9 capsids. Vectors carrying either the Sgcd cDNA or an enhanced green fluorescent protein (EGFP) reporter gene were intravenously injected into adult Sgcd knockout mice. After 6 months, immunohistochemistry revealed almost complete reconstitution of the sarcoglycan subcomplex in heart but not skeletal muscle of mice with the Sgcd vector. Furthermore, Sgcd gene transfer resulted in prevention of cardiac fibrosis and significantly increased running distance measured by voluntary wheel running. Left ventricular function remained stable in mice expressing Sgcd while it deteriorated in EGFP controls within 6 months, paralleled by increased expression of brain natriuretic peptide, a molecular marker of heart failure., Conclusion: Our study establishes an approach to specifically treat hereditary cardiomyopathies by targeting gene expression into the myocardium upon systemic application of AAV vectors.
- Published
- 2009
- Full Text
- View/download PDF
14. Incomplete nonsense-mediated decay of mutant lamin A/C mRNA provokes dilated cardiomyopathy and ventricular tachycardia.
- Author
-
Geiger SK, Bär H, Ehlermann P, Wälde S, Rutschow D, Zeller R, Ivandic BT, Zentgraf H, Katus HA, Herrmann H, and Weichenhan D
- Subjects
- Adult, Alleles, Case-Control Studies, Cell Nucleus metabolism, Chromatin metabolism, Down-Regulation, Female, Fibroblasts metabolism, Health, Humans, Male, Myocardium metabolism, Nuclear Proteins metabolism, Pedigree, Proteasome Inhibitors, RNA, Messenger genetics, RNA, Messenger metabolism, Skin metabolism, Skin pathology, Cardiomyopathy, Dilated genetics, Codon, Nonsense genetics, Lamin Type A metabolism, Mutant Proteins metabolism, RNA Stability, Tachycardia, Ventricular genetics
- Abstract
We have identified a family in which several members died of sudden cardiac death or suffer from dilated cardiomyopathy (DCM) and rhythm disturbances. Mutation screening revealed co-segregation of a novel nonsense mutation (pR321X) in the lamin A gene, LMNA, with the disease. Lamin A, and its smaller splice form lamin C are nuclear intermediate filament proteins forming a major part of the lamina, which is underlying the inner nuclear membrane. They are involved in the organization of heterochromatin and both in DNA replication and transcription. Recently, an increasing number of missense mutations in LMNA have been discovered to cause various types of rare diseases. Here, we investigated the causal role of the new nonsense mutation for the disease. Quantification of wild type and mutant lamin A mRNA from explanted myocardial tissue and cultured fibroblasts revealed an up to 30-fold reduction in the relative amount of the mutant transcript indicating that its synthesis was massively down-regulated by nonsense-mediated mRNA decay (NMD). Correspondingly, we did not detect the mutant truncated lamin A by Western blot analysis in extracts of patient fibroblasts and cardiac muscle tissue. Both wild type lamin A and C were present, however, in normal quantities. The immunohistochemical analyses of patient tissues revealed a normal distribution of lamin A/C and of major inner nuclear membrane proteins such as emerin and the lamin B receptor. Moreover, both chromatin distribution and nuclear shape were normal. However, over-expression of truncated lamin A in HeLa cells by transient transfection caused major disturbances of lamin A organization within both the nucleoplasm and the cytoplasm. In addition, after treatment of patient fibroblasts with the proteasome inhibitor epoxomicin, mutant truncated lamin A was detected in relatively high levels by Western blotting demonstrating that it is synthesized in these cells. Therefore, we conclude that NMD is not sufficient to completely prevent the expression of truncated lamin A and that even trace amounts of it may negatively interfere with structural and/or regulatory functions of lamin A/C eventually leading to the development of DCM and rhythm disturbances.
- Published
- 2008
- Full Text
- View/download PDF
15. Centromeric association of chromosome 16- and 18-derived microchromosomes.
- Author
-
Felbor U, Rutschow D, Haaf T, and Schmid M
- Subjects
- Adult, Chromosome Aberrations, Chromosome Banding, DNA Probes genetics, DNA, Satellite, Female, Fibroblasts physiology, Humans, In Situ Hybridization, Fluorescence, Infant, Newborn, Karyotyping, Lymphocytes physiology, Metaphase genetics, Centromere genetics, Chromosomes, Human, Pair 16 genetics, Chromosomes, Human, Pair 18 genetics
- Abstract
A supernumerary C-band-positive microchromosome was observed in 88% of lymphocyte metaphases from a healthy 24-year-old female. Traditional cytogenetic analyses failed to determine the microchromosome's origin and structure. However, hybridization experiments with a panel of chromosome-specific alpha-satellite probes demonstrated that this microchromosome was derived from chromosome 16 and consisted mainly of transcriptionally inactive alpha-satellite DNA. The microchromosome closely associated with the centromere of most chromosomes. An even more pronounced centromeric association pattern was observed in a further microchromosome that was found to contain chromosome 18-specific alpha-satellite DNA. The latter microchromosome was detected in a female newborn affected with fetal alcohol syndrome. The two microchromosomes described here did not appear to bear major phenotypic risks.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.